French cosmetics giant L’Oréal has been granted a business licence in China to market its Episkin reconstructed skin model. It will market the technology through Shanghai Episkin Biotechnology.
China gives L’Oréal the Episkin all clear
French cosmetics giant L’Oréal has been granted a business licence in China to market its Episkin reconstructed skin model
You need to be a subscriber to read this article. 
Click here to find out more.
                                    Click here to find out more.
You may also like
Trending Articles
You may also like
You need to be a subscriber to read this article.
                                            
Click here to find out more.
                                Click here to find out more.
You need to be a subscriber to read this article.
                                            
Click here to find out more.
                                Click here to find out more.
You need to be a subscriber to read this article.
                                            
Click here to find out more.
                                Click here to find out more.
You need to be a subscriber to read this article.
                                            
Click here to find out more.
                                Click here to find out more.
                                                            Research & Development
                                                        
                                
                                                                            
                                                                    
                                
                    L’Oréal is fuelling the future of AI – and it is only just getting started
Guive Balooch, Head of Augmented Beauty & Open Innovation at L’Oréal Groupe, pulls back the curtain on L’Oréal’s artificial intelligence (AI) strategy and his role in taking the business’ technology to new heights
                                                                    
                                
                            
                        